on ABIONYX (EPA:ABNX)
ABIONYX Pharma Secures Approval for All General Meeting Resolutions
ABIONYX Pharma, a biotech firm known for its innovative approaches to therapy development, has successfully garnered approval for all resolutions put forth at its Combined General Meeting. The meeting took place on June 27th, 2025, with shareholders participating in various capacities, including in-person, by representation, or via postal voting. These approvals reflect strong shareholder backing for the company's strategic objectives.
The company expressed gratitude towards its shareholders for their continued support. Detailed minutes and voting outcomes from the meeting are accessible in the Shareholder Meeting section of ABIONYX Pharma's website.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIONYX news